Liver Function Changes in Patients with Hepatocellular Carcinoma Treated with Lenvatinib: Predictive Factors of Progression to Child-Pugh Class B, the Formation of Ascites and the Candidates for the Post-Progression Treatment

SIMPLE SUMMARY: Many drugs has become available for the advanced hepatocellular carcinoma and sequential systemic therapies play an important role in the clinical settings. Because the key eligibility criteria for post-progression treatment included the performance status of ≦1 and Child-Pugh score...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatanaka, Takeshi, Kakizaki, Satoru, Nagashima, Tamon, Namikawa, Masashi, Ueno, Takashi, Tojima, Hiroki, Takizawa, Daichi, Naganuma, Atsushi, Arai, Hirotaka, Sato, Ken, Harimoto, Norifumi, Shirabe, Ken, Uraoka, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601832/
https://www.ncbi.nlm.nih.gov/pubmed/33050527
http://dx.doi.org/10.3390/cancers12102906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601832/
https://www.ncbi.nlm.nih.gov/pubmed/33050527
http://dx.doi.org/10.3390/cancers12102906

Ejemplares similares